pazopanib (Votrient)
Jump to navigation
Jump to search
Indications
- chemotherapy for advanced renal cell carcinoma
- soft tissue sarcoma[3]
Dosage
tablets: 200 mg
Monitor
- liver function tests (serum ALT, serum bilirubin) at baseline, at least every 4 weeks for the 1st 4 months, then periodically[2]
Drug interactions
Mechanism of action
More general terms
References
- ↑ Prescriber's Letter 17(2): 2010 New Drugs Approved by the FDA in 2009 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=260213&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 2.0 2.1 Prescriber's Letter 17(7): 2010 Recommended Lab Monitoring for Common Medications Liver Function Test Scheduling Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=260704&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 3.0 3.1 Deprecated Reference